BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhattacharyya A, Zhao X. Human pluripotent stem cell models of Fragile X syndrome. Mol Cell Neurosci 2016;73:43-51. [PMID: 26640241 DOI: 10.1016/j.mcn.2015.11.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Salari S, Adashi EY, Keller L, Johnson TRB, Smith GD. Human embryos donated for human embryonic stem cell derivation. Fertil Steril 2023;119:3-10. [PMID: 36494202 DOI: 10.1016/j.fertnstert.2022.10.023] [Reference Citation Analysis]
2 Talvio K, Minkeviciene R, Townsley KG, Achuta VS, Huckins LM, Corcoran P, Brennand KJ, Castrén ML. Reduced LYNX1 expression in transcriptome of human iPSC-derived neural progenitors modeling fragile X syndrome. Front Cell Dev Biol 2022;10:1034679. [PMID: 36506088 DOI: 10.3389/fcell.2022.1034679] [Reference Citation Analysis]
3 Prem S, Dev B, Peng C, Mehta M, Alibutud R, Connacher RJ, Thomas MS, Zhou X, Matteson P, Xing J, Millonig JH, Dicicco-bloom E. Dysregulation of mTOR Signaling Mediates Common Neurite and Migration Defects in Both Idiopathic and 16p11.2 Deletion Autism Neural Precursor Cells.. [DOI: 10.1101/2022.09.17.508382] [Reference Citation Analysis]
4 Lee A, Xu J, Wen Z, Jin P. Across Dimensions: Developing 2D and 3D Human iPSC-Based Models of Fragile X Syndrome. Cells 2022;11. [PMID: 35681419 DOI: 10.3390/cells11111725] [Reference Citation Analysis]
5 Dias CM, Talukdar M, Akula SK, Walsh K, Walsh CA. Glial dysregulation in human brain in Fragile X-related disorders.. [DOI: 10.1101/2022.03.29.486195] [Reference Citation Analysis]
6 Liu X, Kumar V, Tsai N, Auerbach BD. Hyperexcitability and Homeostasis in Fragile X Syndrome. Front Mol Neurosci 2022;14:805929. [DOI: 10.3389/fnmol.2021.805929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Hunt JFV, Li M, Risgaard R, Ananiev GE, Wildman S, Zhang F, Bugni TS, Zhao X, Bhattacharyya A. High Throughput Small Molecule Screen for Reactivation of FMR1 in Fragile X Syndrome Human Neural Cells. Cells 2021;11:69. [DOI: 10.3390/cells11010069] [Reference Citation Analysis]
8 Richter JD, Zhao X. The molecular biology of FMRP: new insights into fragile X syndrome. Nat Rev Neurosci 2021;22:209-22. [PMID: 33608673 DOI: 10.1038/s41583-021-00432-0] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 43.0] [Reference Citation Analysis]
9 Ren B, Dunaevsky A. Modeling Neurodevelopmental and Neuropsychiatric Diseases with Astrocytes Derived from Human-Induced Pluripotent Stem Cells. Int J Mol Sci 2021;22:1692. [PMID: 33567562 DOI: 10.3390/ijms22041692] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
10 Prem S, Millonig JH, DiCicco-Bloom E. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders. Adv Neurobiol 2020;25:109-53. [PMID: 32578146 DOI: 10.1007/978-3-030-45493-7_5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 4.7] [Reference Citation Analysis]
11 Zhao X, Bhattacharyya A. Advances in Human Stem Cells and Genome Editing to Understand and Develop Treatment for Fragile X Syndrome. Adv Neurobiol 2020;25:33-53. [PMID: 32578143 DOI: 10.1007/978-3-030-45493-7_2] [Reference Citation Analysis]
12 Das Sharma S, Pal R, Reddy BK, Selvaraj BT, Raj N, Samaga KK, Srinivasan DJ, Ornelas L, Sareen D, Livesey MR, Bassell GJ, Svendsen CN, Kind PC, Chandran S, Chattarji S, Wyllie DJA. Cortical neurons derived from human pluripotent stem cells lacking FMRP display altered spontaneous firing patterns. Mol Autism 2020;11:52. [PMID: 32560741 DOI: 10.1186/s13229-020-00351-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bagni C, Zukin RS. A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders. Neuron 2019;101:1070-88. [PMID: 30897358 DOI: 10.1016/j.neuron.2019.02.041] [Cited by in Crossref: 140] [Cited by in F6Publishing: 146] [Article Influence: 35.0] [Reference Citation Analysis]
14 Silva MC, Haggarty SJ. Human pluripotent stem cell-derived models and drug screening in CNS precision medicine. Ann N Y Acad Sci 2020;1471:18-56. [PMID: 30875083 DOI: 10.1111/nyas.14012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
15 Pal R, Bhattacharya A. Modelling Protein Synthesis as A Biomarker in Fragile X Syndrome Patient-Derived Cells. Brain Sci 2019;9:E59. [PMID: 30862080 DOI: 10.3390/brainsci9030059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
16 Abu Diab M, Eiges R. The Contribution of Pluripotent Stem Cell (PSC)-Based Models to the Study of Fragile X Syndrome (FXS). Brain Sci 2019;9:E42. [PMID: 30769941 DOI: 10.3390/brainsci9020042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Zhao X, Bhattacharyya A. Human Models Are Needed for Studying Human Neurodevelopmental Disorders. Am J Hum Genet 2018;103:829-57. [PMID: 30526865 DOI: 10.1016/j.ajhg.2018.10.009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 12.6] [Reference Citation Analysis]
18 Zhao X, Moore DL. Neural stem cells: developmental mechanisms and disease modeling. Cell Tissue Res 2018;371:1-6. [PMID: 29196810 DOI: 10.1007/s00441-017-2738-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
19 Sahni G, Chang S, Teo JCM, Fatien JJC, Utami KH, Pouladi M, Toh Y. Spatio-Temporally Patterned Neuroectoderm Tissue Recapitulates Early Neural Tube Morphogenesis and Pathogenesis. SSRN Journal. [DOI: 10.2139/ssrn.3231850] [Reference Citation Analysis]
20 Silva M, Cross A, Brandon N, Haggarty S. Human iPSC Models in Drug Discovery: Opportunities and Challenges. Comprehensive Medicinal Chemistry III 2017. [DOI: 10.1016/b978-0-12-409547-2.12284-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
21 Polak U, Li Y, Butler JS, Napierala M. Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming. Stem Cells Dev 2016;25:1788-800. [PMID: 27615158 DOI: 10.1089/scd.2016.0147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
22 Karmacharya R, Haggarty SJ. Stem cell models of neuropsychiatric disorders. Mol Cell Neurosci 2016;73:1-2. [PMID: 27013423 DOI: 10.1016/j.mcn.2016.03.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
23 Haggarty SJ, Silva MC, Cross A, Brandon NJ, Perlis RH. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models. Mol Cell Neurosci 2016;73:104-15. [PMID: 26826498 DOI: 10.1016/j.mcn.2016.01.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]